Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SABSW

SAB Biotherapeutics, Inc.

CIK 0001833214 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.03
↓ 0.00 (-3.57%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Ownership, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$2.06M
P/E Ratio
-5.18
EPS
0.22
Dividend Yield
Not covered
52W Position
13%
Beta
1.44

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.01
P/S
Not covered
EV/Revenue
Not covered
ROE
-0.2%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 13%
$0.00$0.20

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
$13.27M
Total Assets
$172.81M
Free Cash Flow
-$45.71M

Recent news